News | Cardiovascular Ultrasound | June 13, 2016

Calculating Aortic Flow Rate Superior Test for Patient Risk Stratification

Mayo Clinic study finds echocardiography suitable test to evaluate heart function via dobutamine response

ASE 2016, Mayo Clinic study, echocardiography, aortic flow rate, patient risk stratification

June 13, 2016 — Researchers from Mayo Clinic believe they have found a better way to risk stratify some of their most fragile patients.

Patients with reduced left ventricular ejection fraction (LFLGAS) being evaluated with dobutamine, a medically induced “stressor,” to view their heart function at work need special care. Looking at a cohort of these patients, the researchers found that using echocardiography to measure their aortic flow rate was a good predictor for their risk. “Our work highlights, for the first time, the importance of calculating aortic valve flow rate to risk stratify patients undergoing dobutamine stress echo for a low-flow, low-gradient aortic stenosis. We showed that flow rate goes above and beyond contractile reserve, which is what is being used right now, to risk stratify these patients,” said Said Alsidawi, M.D.

Researchers on the study, Low-flow, Low-gradient Aortic Stenosis: Prognostic Value of Flow Rates vs. Stroke Volume During Dobutamine Echocardiography, included Alsidawi, Robert B. McCully, Christopher G. Scott, Sorin V. Pislaru, Patricia A. Pellikka, Mackram F. Eleid, Jae K. Oh, and Vuyisile T. Nkomo from the Division of Cardiovascular Diseases, Mayo Clinic School of Medicine, Rochester, Minn.

This finding could be useful for many clinicians as patients presenting with low ejection fractions (EF) could be exhibiting an early sign of heart failure. These clinicians need good diagnostic options to assess whether valve replacement surgery or other therapies are needed.

Alsidawi presented a poster based on this research during the American Society of Echocardiography 27th Annual Scientific Sessions, June 10-14 in Seattle. This research was submitted as part of the “Valvular Heart Disease” topic area.

For more information: www.asescientificsessions.org

Related Content

News | ASE
May 5, 2022 – The American Society of Echocardiography (ASE), the largest global organization for cardiovascular ...
Home May 05, 2022
Home
News | ASE
April 21, 2022 – The American Society of Echocardiography (ASE) is pleased to announce that its membership has elected ...
Home April 21, 2022
Home
News | ASE

June 29, 2021 – The virtual exhibit hall at American Society of Echocardiography (ASE) 2021 Scientific Sessions Virtual ...

Home June 29, 2021
Home
News | ASE

August 20, 2020 – More than 350 posters featuring cutting edge research on the advances in cardiovascular ultrasound ...

Home August 20, 2020
Home
Feature | ASE

August 19, 2020 — From point-of-care ultrasound (POCUS) that has been a key technology during the COVID-19 pandemic, to ...

Home August 19, 2020
Home
Feature | ASE

More than 60 companies and organizations are displaying their latest products and services at the 2018 American Society ...

Home June 22, 2018
Home
Feature | ASE

June 26, 2017 — Here is a list of some key clinical presentations and video interviews with cardiac ultrasound thought ...

Home June 26, 2017
Home
Feature | ASE

ASE Announces Meeting Highlights for 28th Annual Scientific Sessions — The program includes learning opportunities from ...

Home June 01, 2017
Home
Videos | ASE

DAIC/ITN editor Dave Fornell shares some of the innovative new technologies on the show floor of the American Society of ...

Home June 30, 2016
Home
Subscribe Now